Related Experiment Video
Updated: May 12, 2025
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
8.2K
Human pluripotent stem cell-based cardiac repair: Lessons learned and challenges ahead
E Coulter Montague1, Bilgehan Ozcan2, Elana Sefton1
1Department of Biomedical Engineering, University of Toronto, ON, Canada; McEwen Stem Cell Institute, University Health Network, Toronto, ON, Canada.
Advanced Drug Delivery Reviews
|May 7, 2025
Summary
Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and cardiac progenitors (hPSC-CPs) show promise for heart repair after myocardial infarction (MI). Preclinical studies reveal engraftment, functional improvement, and arrhythmogenic risks, guiding clinical translation.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Therapy
Background:
- Myocardial infarction (MI) causes significant heart damage, necessitating regenerative strategies.
- Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and cardiac progenitors (hPSC-CPs) are being investigated for cardiac repair.
- Extensive preclinical testing in animal models has preceded recent clinical trials.
Purpose of the Study:
- To review key lessons from preclinical transplantation studies of hPSC-CMs and hPSC-CPs in MI models.
- To identify advancements, challenges, and future directions for hPSC-based cardiac regeneration.
- To summarize evidence regarding graft engraftment, functional recovery, and electromechanical integration.
Main Methods:
- Review of published preclinical transplantation studies involving hPSC-CMs and hPSC-CPs in myocardial infarction models.
- Analysis of data focusing on cell engraftment, graft survival, functional improvement, and electromechanical properties.
- Identification of common findings, limitations, and translational barriers across studies.
Main Results:
- hPSC-CMs and hPSC-CPs demonstrate stable engraftment and partial remuscularization of infarct scars, though cell retention and survival require improvement.
- Transplantation of these cells enhances contractile function in infarcted hearts, but the underlying mechanisms are not fully understood.
- Graft tissue can achieve synchronous electromechanical integration with the host myocardium, albeit with an increased risk of arrhythmias.
Conclusions:
- Preclinical data support the potential of hPSC-CMs and hPSC-CPs for cardiac regeneration, showing engraftment, functional benefits, and integration capabilities.
- Significant challenges remain in improving graft cell survival and mitigating the risk of arrhythmias associated with electromechanical integration.
- Ongoing research focuses on enhancing the safety and efficacy of hPSC-based therapies for heart regeneration.
Related Concept Videos
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:06Induced Pluripotent Stem Cells
3.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.8K